J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them ...

The Swiss medication giant reported three meetings with federal officials in the past week, two of which were with Health ...

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

From Canada to South Korea, you may be surprised at just how international your makeup bag actually is. Here's how the Trump ...

The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of ...

Roche devastated the Angelman syndrome community in 2023, when it ended clinical development of rugonersen, a treatment ...

Roche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx ...

Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...

Arsenal were unable to reproduce their midweek form against Real Madrid as they were held to a disappointing draw by ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...